CHOOLIP & SCIENCES Inc. (KOSDAQ:291650)
South Korea · Delayed Price · Currency is KRW 1,844.00
+85.00 (4.83%)
At close: Sep 23, 2026
CHOOLIP & SCIENCES Market Cap
CHOOLIP & SCIENCES has a market cap or net worth of 56.28 billion as of September 25, 2026. Its market cap has increased by 83.40% in one year.
Market Cap
56.28B
Enterprise Value
51.65B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,844.00
ChartMarket Cap Chart
Since September 16, 2020, CHOOLIP & SCIENCES's market cap has decreased from 234.93B to 56.28B, a decrease of -76.05%. That is a compound annual growth rate of -21.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 56.28B | 84.43% |
| Dec 30, 2025 | 30.51B | -4.74% |
| Dec 30, 2024 | 32.03B | -47.67% |
| Dec 28, 2023 | 61.21B | -17.60% |
| Dec 29, 2022 | 74.29B | -48.53% |
| Dec 30, 2021 | 144.35B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PanGen Biotech | 65.28B |
| ABION | 60.91B |
| Psomagen | 59.73B |
| NovMetaPharma | 59.46B |
| TegoScience | 58.21B |
| J2KBIO | 53.91B |
| QuadMedicine | 51.04B |
| KoBioLabs | 50.68B |